Suchergebnisse - "Liu, Songyang"

PubPharm (5)

1

miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma

enthalten in: Oncology reports | 2017

von Liu, Y. | Zhang, W. | Liu, S. | +3

RetractionIn: Oncol Rep. 2022 Nov;48(5):. - PMID 36102315

2

Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells

enthalten in: Molecular medicine reports | 2015

von Liu, S. | Zhang, W. | Liu, K. | +2

3

Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo

enthalten in: Oncology reports | 2014

von Liu, S. | Zhang, W. | Liu, K. | +3

RetractionIn: Oncol Rep. 2022 Feb;47(2):. - PMID 34841439

4

Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo

enthalten in: Oncology reports | 2014

von Zhang, W. | Liu, S. | Liu, K. | +3

5

A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression

enthalten in: The Journal of international medical research | 2014

von Zhang, W. | Liu, S. | Liu, K. | +4

1
[1]